The screening of antiviral activity of compounds can be done by several methods, some of which are low-throughput, such as the plaque reduction method, which is a time-consuming, laborious, and subjective measurement. On the other hand, some of the reported screening methods for anti-infection compounds are quantitative and high-throughput, but they often use new technologies, such as expensive equipment and software, which limit their use.